Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | IMDZ | ENTA | NBTX | ||
Company | Immune Design CS | Enanta Pharmaceutica | Nanobiotix S.A. ADR | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 5.84 | 13.70 | 6.01 | ||
High | 5.85 | 13.94 | 6.07 | ||
Low | 5.84 | 13.38 | 6.01 | ||
Last | 5.85 | 13.91 | 6.05 | ||
Change | unch | +0.35 | +0.05 | ||
% Change | unch | +2.58% | +0.83% | ||
Volume | 103,800 | 116,700 | 3,100 | ||
20-Day Average Volume | 409,005 | 149,000 | 81,010 | ||
Previous Close | 5.85 | 13.56 | 6.00 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 5.84 | 14.52 | 5.88 | ||
20-Day Raw Stochastic | 100.00% | 35.36% | 62.59% | ||
20-Day Relative Strength | 88.63% | 47.64% | 49.12% | ||
Weighted Alpha | -20.50 | -47.50 | -24.01 | ||
Today's Opinion | 88% Buy | 40% Buy | 88% Sell | ||
Previous Opinion | 88% Buy | 40% Buy | 88% Sell | ||
Last Month's Opinion | 56% Buy | 88% Buy | 88% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | unch since 03/25/19 | +11.46% since 04/25/24 | +2.37% since 04/25/24 | ||
Low | 5.84 on 04/01/19 | 12.20 on 04/26/24 | 5.70 on 04/29/24 | ||
High | 5.85 on 04/01/19 | 14.27 on 05/01/24 | 6.30 on 04/29/24 | ||
1-Month | |||||
%Chg | +0.34% since 03/01/19 | -14.92% since 04/02/24 | -0.82% since 04/02/24 | ||
Low | 5.82 on 03/14/19 | 12.20 on 04/26/24 | 5.13 on 04/17/24 | ||
High | 5.85 on 04/01/19 | 17.60 on 04/04/24 | 6.60 on 04/05/24 | ||
3-Month | |||||
%Chg | +350.00% since 12/31/18 | +13.27% since 02/02/24 | -17.69% since 02/02/24 | ||
Low | 1.22 on 01/03/19 | 11.01 on 02/08/24 | 5.13 on 04/17/24 | ||
High | 5.85 on 04/01/19 | 17.80 on 04/01/24 | 7.65 on 02/08/24 | ||
6-Month | |||||
%Chg | +73.08% since 10/01/18 | +57.35% since 11/02/23 | +13.30% since 11/02/23 | ||
Low | 1.10 on 12/24/18 | 8.08 on 11/10/23 | 5.13 on 04/17/24 | ||
High | 5.85 on 04/01/19 | 17.80 on 04/01/24 | 8.96 on 01/18/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 282,935 | 286,875 | 282,798 | ||
Shares Outstanding, K | 48,365 | 21,156 | 47,133 | ||
Annual Sales | 2,200,000 | 79,200,000 | 39,190,000 | ||
Annual Net Income | -54,760,000 | -133,820,000 | -42,970,000 | ||
Last Quarter Sales | 480,000 | 18,000,000 | N/A | ||
Last Quarter Net Income | -13,600,000 | -33,410,000 | N/A | ||
60-Month Beta | 3.48 | 0.54 | 0.26 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -1.58 on 02/07/24 | N/A | ||
Latest Earnings Date | 05/01/19 | 05/06/24 | 04/22/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |